JP Morgan Maintains Underweight on Medical Properties Trust, Lowers Price Target to $5
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Michael Lapides has maintained an Underweight rating on Medical Properties Trust (NYSE:MPW) and reduced the price target from $8 to $5.
November 29, 2023 | 7:46 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
JP Morgan analyst Michael Lapides maintained an Underweight rating on Medical Properties Trust and lowered the price target from $8 to $5.
The reduction in price target by a major financial institution like JP Morgan suggests a bearish outlook on the stock, which could lead to a decrease in investor confidence and a potential drop in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100